Cargando…

Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma

Detalles Bibliográficos
Autores principales: Bawany, Fatima, Ramachandran, Vignesh, Rodriguez, Eduardo, Kim, Randie H., Weber, Jeffrey S., Tattersall, Ian W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568223/
https://www.ncbi.nlm.nih.gov/pubmed/37842150
http://dx.doi.org/10.1016/j.jdcr.2023.08.040
_version_ 1785119312808247296
author Bawany, Fatima
Ramachandran, Vignesh
Rodriguez, Eduardo
Kim, Randie H.
Weber, Jeffrey S.
Tattersall, Ian W.
author_facet Bawany, Fatima
Ramachandran, Vignesh
Rodriguez, Eduardo
Kim, Randie H.
Weber, Jeffrey S.
Tattersall, Ian W.
author_sort Bawany, Fatima
collection PubMed
description
format Online
Article
Text
id pubmed-10568223
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105682232023-10-13 Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma Bawany, Fatima Ramachandran, Vignesh Rodriguez, Eduardo Kim, Randie H. Weber, Jeffrey S. Tattersall, Ian W. JAAD Case Rep Case Report Elsevier 2023-09-14 /pmc/articles/PMC10568223/ /pubmed/37842150 http://dx.doi.org/10.1016/j.jdcr.2023.08.040 Text en https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Case Report
Bawany, Fatima
Ramachandran, Vignesh
Rodriguez, Eduardo
Kim, Randie H.
Weber, Jeffrey S.
Tattersall, Ian W.
Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma
title Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma
title_full Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma
title_fullStr Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma
title_full_unstemmed Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma
title_short Linear IgA bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma
title_sort linear iga bullous dermatosis induced by nemvaleukin alfa, an engineered interleukin 2 molecule, in a patient with treatment-refractory metastatic melanoma
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10568223/
https://www.ncbi.nlm.nih.gov/pubmed/37842150
http://dx.doi.org/10.1016/j.jdcr.2023.08.040
work_keys_str_mv AT bawanyfatima linearigabullousdermatosisinducedbynemvaleukinalfaanengineeredinterleukin2moleculeinapatientwithtreatmentrefractorymetastaticmelanoma
AT ramachandranvignesh linearigabullousdermatosisinducedbynemvaleukinalfaanengineeredinterleukin2moleculeinapatientwithtreatmentrefractorymetastaticmelanoma
AT rodriguezeduardo linearigabullousdermatosisinducedbynemvaleukinalfaanengineeredinterleukin2moleculeinapatientwithtreatmentrefractorymetastaticmelanoma
AT kimrandieh linearigabullousdermatosisinducedbynemvaleukinalfaanengineeredinterleukin2moleculeinapatientwithtreatmentrefractorymetastaticmelanoma
AT weberjeffreys linearigabullousdermatosisinducedbynemvaleukinalfaanengineeredinterleukin2moleculeinapatientwithtreatmentrefractorymetastaticmelanoma
AT tattersallianw linearigabullousdermatosisinducedbynemvaleukinalfaanengineeredinterleukin2moleculeinapatientwithtreatmentrefractorymetastaticmelanoma